Skip to main content

Table 3 The correlation between calpain II expression and clinicopathological parameters in IDC cases

From: Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer

Clinicopathological parameters

Calpain II expression

Positive (%) n = 64

Negative (%) n = 19

P value

ER

  

0.580

 Positive

35 (54.7)

9 (47.4)

 

 Negative

29 (45.3)

10 (52.6)

 

HER2

  

0.597

 Positive

21 (32.8)

5 (26.3)

 

 Negative

43 (67.2)

14 (73.7)

 

pAKT

  

0.029 a

 Positive

50 (78.1)

10 (52.6)

 

 Negative

14 (21.9)

9 (47.4)

 

pmTOR

  

0.011 a

 Positive

52 (81.3)

10 (52.6)

 

 Negative

12 (18.8)

9 (47.4)

 

p4E-BP1

  

< 0.001 a

 Positive

52 (81.3)

6 (31.6)

 

 Negative

12 (18.8)

13 (68.4)

 

p-p70S6K

  

0.003 a

 Positive

52 (81.3)

9 (47.4)

 

 Negative

12 (18.8)

10 (52.6)

 

Stage

  

0.773

 Stage I

7 (10.9)

1 (5.3)

 

 Stage II

37(57.8)

14 (73.7)

 

 Stage III

20 (31.3)

4 (21.2)

 

Grade

  

0.568

 Grade I

16 (25.0)

3 (15.8)

 

 Grade II

35 (54.7)

12 (63.2)

 

 Grade III

13 (20.3)

4 (21.1)

 

Nodal status

  

0.876

 Positive

45 (70.3)

13 (68.4)

 

 Negative

19 (29.7)

6 (31.6)

 

Distant metastasis

  

0.122

 Positive

26 (40.6)

4 (21.1)

 

 Negative

38 (59.4)

15 (78.9)

 

Tumor size

  

0.013 a

 ≦4 cm

34 (53.1)

4 (21.1)

 

 > 4 cm

30 (46.9)

15 (78.9)

 

Age

  

0.653

 ≦55 yrs

44 (68.8)

12 (63.2)

 

 > 55 yrs

20 (31.3)

7 (36.8)

 
  1. aStatistically significant p values are in bold